Involvement of mitochondrial aggregation in arsenic trioxide (As2O3)‐induced apoptosis in human glioblastoma cells
Authors:
Open Access
- 14 October 2005
- journal article
- Published by Wiley in Cancer Science
- Vol. 96 (11) , 825-833
Abstract
Arsenic trioxide (As2O3) is effective against acute promyelocytic leukemia and has potential as a novel treatment against malignant solid tumors. As2O3 induces differentiation and inhibits growth. It also causes mitochondrial damage mediated by the production of reactive oxygen species (ROS) and the dissipation of mitochondrial transmembrane potential (ΔΨm), leading to apoptosis. Mitochondria might be the key target of antitumor activity by As2O3; however, its mechanisms have not been completely elucidated. Using two human glioblastoma cell lines, A172 and T98G, we found that As2O3 induced apoptosis in A172 cells but not in T98G cells. As2O3‐induced ROS production was observed in both cell lines; however, the dissipation of ΔΨm, Bax oligomerization and caspase activation occurred only in As2O3‐sensitive A172 cells. To determine the mechanisms of As2O3‐induced apoptosis after ROS generation, we examined the change of mitochondrial morphology. As we reported previously, mitochondrial aggregation occurs before cytochrome c release during apoptosis, thus playing a role in cell death progression. We observed mitochondrial aggregation in As2O3‐sensitive A172 cells but not in T98G cells treated with As2O3. Using laser scanning cytometry, we quantitatively confirmed the results, which indicate that mitochondrial aggregation plays an important role in regulating sensitivity to As2O3‐induced apoptosis. We propose a sequential process involving ROS generation, mitochondrial aggregation, Bax oligomerization and ΔΨm dissipation, and caspase activation during As2O3‐induced apoptosis. (Cancer Sci 2005; 96: 825–833)Keywords
This publication has 53 references indexed in Scilit:
- Neuro-oncology: the growing role of chemotherapy in gliomaThe Lancet Neurology, 2005
- Development of gliomas: potential role of asymmetrical cell division of neural stem cellsThe Lancet Oncology, 2004
- The victorin‐induced mitochondrial permeability transition precedes cell shrinkage and biochemical markers of cell death, and shrinkage occurs without loss of membrane integrityThe Plant Journal, 2004
- A decade of caspasesOncogene, 2003
- Sustained activation of c-jun-terminal kinase (JNK) is closely related to arsenic trioxide-induced apoptosis in an acute myeloid leukemia (M2)-derived cell line, NKM-1Leukemia, 2003
- Docosahexaenoic acid enhances arsenic trioxide–mediated apoptosis in arsenic trioxide–resistant HL-60 cellsBlood, 2003
- Mitochondrion as a Novel Target of Anticancer ChemotherapyJNCI: Journal of the National Cancer Institute, 2000
- Effect of Arsenic Trioxide on Cell Cycle Arrest in Head and Neck Cancer Cell Line PCI-1Biochemical and Biophysical Research Communications, 1999
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995